DISCLAIMER
The guidance contained herein, is provided for informational purposes only and represents no statement, promise, or guarantee by BioTissue Holdings Inc. or its operating subsidiaries, including BioTissue Ocular Inc.(collectively BioTissue) concerning reimbursement, payment, or charges. It is always the provider’s responsibility to determine and submit approrpiate codes, modifiers, and charges that reflect services provided. CPT codes and HCPCS codes are supplied for informational purposes only and represent no statement, promise, or guarantee by BioTissue that these code selections will be appropriate for a given service or that reimbursement will be made to the provider. This information is not intended to increase or maximize reimbursement by a Payor. BioTissue strongly recommends that you consult your individual Payor Organization regarding its relative and current reimbursement policies. For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package inserts.
Prokera®, CAM360 AmnioGraft™, and AmnioGraft®
Ocular
To ensure a patient meets their carrier’s medical necessity policy criteria, or to find out if a Prior Authorization or Pre-Determination is required, it is recommended that you contact the patient’s payor directly or utilize www.availity.com.
Assigned CPT code for Prokera, CAM360 AmnioGraft, and AmnioGraft:
65778 | Placement of Amniotic membrane on the ocular surface, without sutures
Questions about Ocular reimbursement?
Reach out to our team: [email protected]
or…
The Pinnacle Health Group
BioTissue has a Reimbursement Support Hotline which is available by contacting The Pinnacle Health Group.
[email protected]
Phone: 866-369-9290
Fax: 877-499-2986
Hours: Mon. – Fri., 8:30 AM – 6:00 PM ET
2026 BioTissue Ocular Resource Guide
2026 BioTissue Ocular Coding Sheets
For Prokera, CAM360 AG, and AmnioGraft
*Information contained on this page is provided as a reference and for informational purposes only.
